DEVATIS INC.
As the parent company, DEVA Holding A.S., a long established multinational company headquartered in Istanbul, Turkey which is active since 1958 in pharmaceutical sector owns 100% of Devatis, Inc. shares. In addition to its activities in Turkey and various European and significant eastern territories, DEVA Holding A.S. has stepped into the territory of the USA by incorporating Devatis Inc. In order to expand its services to human health in the US, Philipp D. Haas, having broad experience in pharmaceuticals business in various markets, is actively contributing to improve Devatis, Inc. and is acting as the President of Devatis Inc. which develops, markets and distributes quality branded pharmaceutical products directly. Devatis, Inc. adheres to strict cGMP standards and has an excellent audit history with the US Food and Drug Administration (FDA). With over 60 years of combined pharmaceutical experience in public and private sectors in more than 60 countries, the leadership team is responsible for implementing business strategy assuring long-term success. Strategic partnerships are a vital component of current and future growth. About DEVA Holding
Country/Area ：United States
Company Email ：info@devatis.com
Industry ：Health & MedicalManufacturing GeneralManufacturingPharmaceuticals
Company address ：2800 W State Road 84 Ste 118, Dania, Florida, 33004, United States
Company website ：*****
Company phone ：(954) 316-4844
Established ：2020
Company Revenue ：$2,651,000
Number of employees ：1-10
SIC Code ：28283
NAICS Code ：32325
Main Products ：respiratory systemneuroscienceinfectious diseasesophthalmologyoncology
Web Summary
Q1: What is the company name and its location?
A1: The company name is Devatis Inc., and it has locations in various countries across four continents, including Australia, Austria, Azerbaijan, Canada, Germany, Mexico, Netherlands, New Zealand, Serbia, Switzerland, and the USA.
Q2: What industry does Devatis Inc. operate in?
A2: Devatis Inc. operates in the pharmaceutical industry, specifically in the development and manufacturing of pharmaceutical products.
Q3: What is the company's mission statement?
A3: The company's mission statement is to deliver excellent, dynamic, and reliable pharmaceutical solutions worldwide while redefining global healthcare standards.
Q4: Where can one find more information about Devatis Inc.?
A4: One can find more information about Devatis Inc. on its official website, which includes sections for "Who We Are", "Our Expertise", "News & Events", "Quality", and "Join Us".
Q5: What is the company's commitment to quality and safety?
A5: The company is committed to delivering high-quality pharmaceutical solutions by manufacturing products in state-of-the-art facilities certified by US FDA and EU GMP standards.
Q6: Who is the CEO of Devatis Inc.?
A6: Philipp D. Haas is the CEO of Devatis Inc., who emphasizes the company's commitment to improving global health through innovative pharmaceutical solutions.
Q7: What are some of the specialized areas that Devatis Inc. focuses on?
A7: Devatis Inc. has specialized areas in Acute Infectious Diseases and Nutrition, Metabolism and Hormones, Organ and System Based Therapies, Oncology & Hematology, Ophthalmology, Cardiology, Respiratory Musculoskeletal System, Blood & Blood Forming Organs, and Dermatology.
Q8: What is the company's approach to innovation?
A8: Devatis Inc. aims to create lasting value and set new benchmarks in global healthcare through precision, quality, and patient-centric innovation, guided by a clear purpose of redefining global healthcare standards.
A1: The company name is Devatis Inc., and it has locations in various countries across four continents, including Australia, Austria, Azerbaijan, Canada, Germany, Mexico, Netherlands, New Zealand, Serbia, Switzerland, and the USA.
Q2: What industry does Devatis Inc. operate in?
A2: Devatis Inc. operates in the pharmaceutical industry, specifically in the development and manufacturing of pharmaceutical products.
Q3: What is the company's mission statement?
A3: The company's mission statement is to deliver excellent, dynamic, and reliable pharmaceutical solutions worldwide while redefining global healthcare standards.
Q4: Where can one find more information about Devatis Inc.?
A4: One can find more information about Devatis Inc. on its official website, which includes sections for "Who We Are", "Our Expertise", "News & Events", "Quality", and "Join Us".
Q5: What is the company's commitment to quality and safety?
A5: The company is committed to delivering high-quality pharmaceutical solutions by manufacturing products in state-of-the-art facilities certified by US FDA and EU GMP standards.
Q6: Who is the CEO of Devatis Inc.?
A6: Philipp D. Haas is the CEO of Devatis Inc., who emphasizes the company's commitment to improving global health through innovative pharmaceutical solutions.
Q7: What are some of the specialized areas that Devatis Inc. focuses on?
A7: Devatis Inc. has specialized areas in Acute Infectious Diseases and Nutrition, Metabolism and Hormones, Organ and System Based Therapies, Oncology & Hematology, Ophthalmology, Cardiology, Respiratory Musculoskeletal System, Blood & Blood Forming Organs, and Dermatology.
Q8: What is the company's approach to innovation?
A8: Devatis Inc. aims to create lasting value and set new benchmarks in global healthcare through precision, quality, and patient-centric innovation, guided by a clear purpose of redefining global healthcare standards.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
